Bispectral-Electroencephalography (EEG) in First Time Hemodialysis

ConditionRenal Failure Acute Chronic

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-90

SponsorSuez Canal University

About this trial

The severity of minimal dialysis disequilibrium syndrome (DDS) is currently detected and graded clinically using clinical criteria. Bispectral Index (BIS), an electroencephalographic (EEG) derived parameter is widely used in anesthesia and Critical Care setting to detect effects of anesthetic/hypnotic drugs. The aim of our study was to assess the discriminative power of BIS monitoring to accurately detect DDS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

First Time renal Dialysis

Disqualifiers

subjects' consumption of sedatives/hypnotics psychotropic drugs, or concomitant neurological disorders affecting mental state such as hepatic encephalopathy, stroke, stupor or dementia and renal transplant patients.

Trial population

First Time renal Dialysis

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

recording of Bispectral Index
Device
recording of Bispectral Index

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

Change in the Bispectral Index value

Interpatient Change in the value of recorded Bispectral Index between patients undergoing first time hemodialysis (differences between patients) and intrapatient (differences in bispectral Index values between the first 3 hemodialysis sections of each recruited patient)

Time frame

Over a period of one year Time point 1= First Hemodialysis, Time point 2= Second Hemodialysis, Time point 3= Third Hemodialysis.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Suez Canal University

Lead sponsor

Dalian Medical University

Collaborator

Source ClinicalTrials.gov

Apply now